Le Journal des Entreprises highlights EncapX, the encapsulation technology developed by Biotech One to protect and stabilize sensitive molecules.
Key points:
encapsulation of fragile molecules: RNA, peptides, anticancer compounds and gene therapies;
improved stability, shelf-life and deliverability;
a scalable alternative to the limitations of microfluidics;
a solution that can be used from R&D formulation through to scale-up.
EncapX provides a concrete answer to the main bottleneck in encapsulation: moving from the laboratory to industrial production.
Extrait Journal des Entreprises Juin 2026 .pdf
Key points:
encapsulation of fragile molecules: RNA, peptides, anticancer compounds and gene therapies;
improved stability, shelf-life and deliverability;
a scalable alternative to the limitations of microfluidics;
a solution that can be used from R&D formulation through to scale-up.
EncapX provides a concrete answer to the main bottleneck in encapsulation: moving from the laboratory to industrial production.
Extrait Journal des Entreprises Juin 2026 .pdf
